dc.contributor.author | Lalatsa, Lalatsa | |
dc.date.accessioned | 2014-02-06T12:28:57Z | |
dc.date.available | 2014-02-06T12:28:57Z | |
dc.date.issued | 2013-05 | |
dc.identifier.citation | Lalatsa , L 2013 , ' Prefilled syringes or peptide pills? The impact of new delivery technologies in designing peptide therapies ' , Pharmaceutical Technology , vol. 37 , no. 5 , pp. 46-49 . < http://www.pharmtech.com/pharmtech/Feature+Articles/Prefilled-Syringes-or-Peptide-Pills/ArticleStandard/Article/detail/813404?contextCategoryId=40941 > | |
dc.identifier.issn | 1543-2521 | |
dc.identifier.uri | http://hdl.handle.net/2299/12762 | |
dc.format.extent | 4 | |
dc.language.iso | eng | |
dc.relation.ispartof | Pharmaceutical Technology | |
dc.title | Prefilled syringes or peptide pills? : The impact of new delivery technologies in designing peptide therapies | en |
dc.contributor.institution | Department of Pharmacy | |
dc.contributor.institution | Centre for Research into Topical Drug Delivery and Toxicology | |
dc.contributor.institution | Nanopharmaceutics | |
dc.contributor.institution | Pharmaceutics | |
dc.contributor.institution | School of Life and Medical Sciences | |
dc.contributor.institution | Health & Human Sciences Research Institute | |
dc.description.status | Peer reviewed | |
dc.identifier.url | http://www.pharmtech.com/pharmtech/Feature+Articles/Prefilled-Syringes-or-Peptide-Pills/ArticleStandard/Article/detail/813404?contextCategoryId=40941 | |
rioxxterms.type | Journal Article/Review | |
herts.preservation.rarelyaccessed | true | |